 effect indecainid patient left ventricular dysfunct indecainid new antiarrhythm agent type Ic patient heart diseas equal ventricular prematur complexes/hour moderate-to-mark ventricular dysfunct mean eject fraction patient mg mouth hour dose equal suppress advers effect maximum dose mg indecainid hour ventricular prematur complex equal patient ventricular tachycardia episod patient effect maxim mean daili indecainid dose mg half respond achiev efficaci serum drug concentr equal ng/ml serum drug concentr clearanc eject fraction indecainid mean PR qr interv QT qtc linear relat percent chang PR qr interv serum drug concentr dose care observ patient decreas renal function reduc eject fraction drug concentr normal subject